Jul 16

ACT for NIH announces addition of three new members to its prominent Advisory Committee

JULY 16, 2021 – ACT for NIH announced today it has added three new members to its prominent Advisory Committee. They are:

  • Phillip O. Ozuah, M.D., Ph.D., President and CEO, Montefiore Medicine
  • Padmanee Sharma, M.D., Ph.D., Professor, MD Anderson Cancer Center, University of Texas
  • Michael Stephens, M.P.H., Former Staff Director, House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

“We are thrilled to have three such talented advocates and friends join our Advisory Committee,” said ACT for NIH Founder and Chairman Jed Manocherian.  “Dr. Ozuah, Dr. Sharma, and Mr. Stephens are long-time champions of the ACT for NIH mission, and their leadership on our Advisory Committee will further our efforts to alleviate suffering and death for countless millions across the globe.  There are too many patients to be patient.”

ACT for NIH President Richard Turman joined Mr. Manocherian in expressing gratitude to the new members of the Advisory Committee.  “Over the last several years, ACT for NIH and our advisory committee have led successful advocacy efforts to increase base funding for NIH and ensure that biomedical research is supported by consistent, robust investment from Congress.  Now, more than ever, the health of our country relies on this investment – we need a robust increase to the NIH base budget this year in order to continue and leverage life-saving research underway at NIH.  From coronavirus to cancer, Alzheimer’s to heart disease, we are on the cusp of innovations that could change our future.”

These new members join the current Advisory Committee made up of award-winning researchers, academic leaders, philanthropists, and passionate advocates for medical research:

  • James Allison, Ph.D., Nobel Prize Winner; Professor, MD Anderson Cancer Center, University of Texas
  • David Baltimore, Ph.D., Nobel Prize Winner; President Emeritus, California Institute of Technology
  • The Honorable Eric Cantor, Former House Majority Leader; Vice Chairman and Managing Director, Moelis & Company
  • Ronald DePinho, M.D., Past President and Professor, MD Anderson Cancer Center, University of Texas
  • Jennifer Doudna, Ph.D., Nobel Prize Winner; Professor, University of California at Berkeley
  • Bernadette Gray-Little, Ph.D., Former Chancellor, University of Kansas
  • The Honorable Tom Harkin, Former U.S. Senator; Founder, The Harkin Institute for Public Policy and Citizen Engagement
  • Michael Milken, M.B.A., Chairman, The Milken Institute; Public Health Advocate
  • Siddhartha Mukherjee, M.D., Ph.D., Pulitzer Prize-Winning Author; Assistant Professor, Columbia University
  • Sean Parker, Founder and Chairman, The Parker Foundation
  • Ronald Petersen, M.D., Ph.D., Director, Mayo Alzheimer’s Disease Research Center; Professor, Mayo Clinic College of Medicine
  • Lori Wilson, M.D., Associate Professor, Howard University College of Medicine